Biogen Idec Inc (BIIB) 309.43 $BIIB
Jim Cramer's 'Mad Money' Recap: Beware the Market's FANGs
at The Street - Mon Jul 27, 7:16PM CDT
Cramer says this is the thinnest market we've seen in ages, and that's not good.
CERS: 5.20 (+0.01), MMM: 148.71 (-0.62), AMZN: 531.41 (+1.99), BIIB: 309.43 (+9.40), MDLZ: 42.03 (unch), EA: 71.22 (-1.07), SNA: 157.09 (-2.65), NKE: 111.73 (-1.26), MDSO: 52.83 (-0.27), FB: 94.17 (-2.78), FCX: 11.37 (-0.92), COP: 50.65 (-1.44), DIS: 118.25 (-0.66), NFLX: 106.43 (-2.91), ISIS: 53.68 (+0.53), QLIK: 39.94 (-0.63), KHC: 77.38 (+0.97), GOOGL: 658.27 (+3.50), ULTA: 166.39 (-3.15), CMCSA: 61.11 (-1.06), GIS: 56.96 (+0.04), SNDK: 61.16 (-0.68)
Which Big-Cap Stocks Are Defying Market Pressure?
at Investor's Business Daily - Mon Jul 27, 5:46PM CDT
When an uptrend comes under pressure, some stocks show action worthy of a drumroll, while others inspire eye rolls. The recent trouble for the uptrend started after the July 20 close. The S&P 500 suffered four distribution days in a row through...
BIIB: 309.43 (+9.40), MNST: 148.76 (-0.13), VRX: 257.30 (+5.38), GILD: 110.54 (-2.29), CMG: 731.44 (+2.65)
5 Things Biogen's Management Wants You to Know
Brian Orelli, The Motley Fool - Motley Fool - Mon Jul 27, 5:00PM CDT
Biogen held a conference call in conjunction with its second-quarter earnings last week. Here are five things that management said that investors should be paying attention to. "We had expected to see a reacceleration of Tecfidera this quarter,...
BIIB: 309.43 (+9.40)
Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
at The Street - Mon Jul 27, 3:30PM CDT
People are "max negative" on Twitter ahead of its earnings report Tuesday, which Jim Cramer doesn't see as unjustified -- at least, in the short term.
AGN: 326.98 (+18.77), BIIB: 309.43 (+9.40), GILD: 110.54 (-2.29), TEVA: 72.00 (+10.15), TWTR: 34.70 (-0.72)
Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.43 (+9.40), PRGO: 193.60 (+7.10), XOM: 79.26 (-0.68), MYL: 56.37 (-9.57), BMY: 64.30 (-1.68), AGN: 326.98 (+18.77), ISRG: 544.15 (-1.93), SBUX: 56.98 (-0.31), HCA: 92.03 (-0.80), IBM: 159.07 (-0.68), GM: 31.05 (-0.01), TEVA: 72.00 (+10.15), SPLK: 70.60 (-3.31), REGN: 540.03 (-1.82), NVS: 101.54 (-0.26)
4 Stocks Breaking Out on Big Volume
at The Street - Mon Jul 27, 1:30PM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
BIIB: 309.43 (+9.40), TERP: 31.33 (+0.48), WAB: 97.93 (+6.59), ENTA: 47.47 (+2.28)
Cramer -- Intel's a Few Bucks Away From a Buy, but PayPal Is One Right Now
at The Street - Mon Jul 27, 11:32AM CDT
Tech stocks were on the minds of viewers Monday morning when they posed their questions to TheStreet's Jim Cramer, including Intel, T-Mobile and PayPal.
BIIB: 309.43 (+9.40), GILD: 110.54 (-2.29), ALTR: 48.92 (-0.19), XON: 54.57 (-2.29), PYPL: 36.39 (-0.61), TMUS: 36.50 (-0.90), TWTR: 34.70 (-0.72), INTC: 28.35 (+0.29)
Cramer -- Be Careful Buying GrubHub, Biogen Is a Battleground
at The Street - Mon Jul 27, 10:38AM CDT
Jim Cramer is not hungry for GrubHub and says Biogen is turning into a battle royale for biotech investors.
BIIB: 309.43 (+9.40), GRUB: 31.01 (-2.78), XBI: 251.78 (-3.60), IBB: 373.58 (-4.00), REGN: 540.03 (-1.82), CELG: 132.56 (-2.34)
Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog
Arpita Dutt - Zacks Investment Research - Mon Jul 27, 9:58AM CDT
Biogen's (BIIB) shares lost more than 20% on issues regarding its oral MS treatment as well as disappointing pipeline updates.
BLUE: 159.49 (+0.58), BIIB: 309.43 (+9.40), LGND: 102.55 (+0.46), AMGN: 165.54 (+6.95), REGN: 540.03 (-1.82), EXEL: 5.44 (-0.15), CELG: 132.56 (-2.34)
3 Signs That the Healthcare Stock Bubble Might Have Just Popped
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 9:42AM CDT
Over the past five years or so, healthcare stocks have been absolutely trouncing the broader markets, leading many to call this unprecedented bull run a "bubble." A deeper look, though, reveals that most of this hypergrowth in the healthcare...
BIIB: 309.43 (+9.40), ILMN: 217.27 (-3.83), ABBV: 69.34 (+1.26)
3 Great Values to Buy on the Nasdaq - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 9:42AM CDT
Since the long term holds good for stocks listed on the Nasdaq, it will be a prudent idea to invest in value stocks despite short-term volatility.
SGYP: 8.19 (+0.28), AMZN: 531.41 (+1.99), BIIB: 309.43 (+9.40), TTMI: 9.14 (-0.01), FB: 94.17 (-2.78), NFLX: 106.43 (-2.91), YHOO: 37.83 (-1.02), QCOM: 61.98 (+0.34), GOOGL: 658.27 (+3.50), ANAC: 144.30 (-3.95), MSFT: 45.35 (-0.59), TECD: 55.52 (+0.51), AAPL: 122.77 (-1.73)
Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up
at The Street - Mon Jul 27, 9:30AM CDT
After cutting its revenue growth forecast, will Biogen buy itself back into investors' good graces?
BLUE: 159.49 (+0.58), BIIB: 309.43 (+9.40), NBIX: 49.34 (-2.16), ISIS: 53.68 (+0.53), SRPT: 32.00 (-0.63), RCPT: 227.09 (-0.91)
Biogen (BIIB) Stock Rebounding Following Bernstein Upgrade
at The Street - Mon Jul 27, 9:30AM CDT
Biogen (BIIB) stock is up after analysts at Bernstein raised their rating to 'outperform' from 'market perform' this morning.
BIIB: 309.43 (+9.40)
Stock Market News for July 27, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 9:10AM CDT
Declines in biotech and commodity related stocks dragged benchmarks down to on the red on Friday
BIIB: 309.43 (+9.40), AMZN: 531.41 (+1.99), MON: 101.46 (-1.40), COP: 50.65 (-1.44), AMGN: 165.54 (+6.95), XOM: 79.26 (-0.68), SLB: 81.76 (-1.14), CELG: 132.56 (-2.34), RIG: 13.11 (-0.15), GILD: 110.54 (-2.29), DD: 56.73 (-0.21), PX: 111.82 (-1.16), CVX: 89.14 (-1.46), DOW: 45.63 (-0.34), REGN: 540.03 (-1.82)
Biogen Enters Collaboration with the Parkinson's Institute and Clinical Center
Business Wire - Mon Jul 27, 6:30AM CDT
Biogen (NASDAQ:BIIB) and the Parkinson's Institute and Clinical Center today announced the formation of a strategic alliance focused on enhancing the understanding of the underlying biology of Parkinson's disease (PD) and the creation of novel tools and programs that could accelerate research and the development of new PD treatments. The agreement will combine the unique clinical expertise and data of the Institute with Biogen's focus on neurodegenerative disease and approach to clinical development.
BIIB: 309.43 (+9.40)
FCX, CLF, BIIB, COF: Jim Cramer's Views
at The Street - Mon Jul 27, 12:00AM CDT
Jim Cramer shares his views on a really bad day and when a leader stumbles. Freeport McMoRan, Google, Biogen and Capital One are among the many stocks discussed here.
BIIB: 309.43 (+9.40), COF: 78.61 (-0.25), GILD: 110.54 (-2.29), FCX: 11.37 (-0.92), RCPT: 227.09 (-0.91), CLF: 2.40 (-0.06), REGN: 540.03 (-1.82), CELG: 132.56 (-2.34)
Biogen Changed the Perception of This Market
at The Street - Sun Jul 26, 5:00PM CDT
Its large drop made people take notice of the haves-have-nots divergence.
BIIB: 309.43 (+9.40), AAPL: 122.77 (-1.73)
BUYINS.NET: WDR, BIIB, LEA Expected To Be Up Before Next Earnings Releases
M2 - Sat Jul 25, 5:06PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and earnings reports. Waddell & Reed Financial Inc (NYSE:WDR), Biogen Idec Inc (NASDAQ:BIIB), Leader Energy Services Ltd (NYSE:LEA) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up Before earnings are released Tuesday:
BIIB: 309.43 (+9.40), WDR: 43.35 (-0.10), LEA: 99.68 (+0.09)
'Fast Money' Panel Weighs Whether to Buy Stocks, Oil on Recent Decline?
at The Street - Sat Jul 25, 4:00AM CDT
The CNBC "Fast Money" traders look at recent earnings and consider whether dips in stock and oil prices present opportunities for investors.
VLO: 64.38 (-1.32), BIIB: 309.43 (+9.40), AMZN: 531.41 (+1.99), BX: 38.10 (-0.16), TSO: 97.11 (-1.83), C: 57.96 (-0.74), GOOGL: 658.27 (+3.50)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jul 24, 7:26PM CDT
Cramer says investors need to keep their powder dry and pounce when the markets put high-quality domestic stocks on sale.
DHI: 26.74 (+0.01), AMZN: 531.41 (+1.99), BIIB: 309.43 (+9.40), CY: 11.57 (-0.31), NSC: 82.80 (-0.16), MDLZ: 42.03 (unch), FB: 94.17 (-2.78), XOM: 79.26 (-0.68), CZR: 4.92 (+0.08), SBUX: 56.98 (-0.31), NFLX: 106.43 (-2.91), CI: 145.90 (+0.18), UA: 96.43 (+0.38), ANTM: 151.50 (+0.64), RLGT: 6.77 (-0.09), BIDU: 197.68 (-8.57), COF: 78.61 (-0.25), GILD: 110.54 (-2.29), R: 87.32 (-0.40), DD: 56.73 (-0.21), GOOGL: 658.27 (+3.50), PG: 79.97 (-0.32), TWTR: 34.70 (-0.72), PEIX: 7.56 (+0.23), CVX: 89.14 (-1.46)
Jim Cramer's 'Mad Money' Recap: Beware the Market's FANGs
at The Street - Mon Jul 27, 7:16PM CDT
Cramer says this is the thinnest market we've seen in ages, and that's not good.
CERS: 5.20 (+0.01), MMM: 148.71 (-0.62), AMZN: 531.41 (+1.99), BIIB: 309.43 (+9.40), MDLZ: 42.03 (unch), EA: 71.22 (-1.07), SNA: 157.09 (-2.65), NKE: 111.73 (-1.26), MDSO: 52.83 (-0.27), FB: 94.17 (-2.78), FCX: 11.37 (-0.92), COP: 50.65 (-1.44), DIS: 118.25 (-0.66), NFLX: 106.43 (-2.91), ISIS: 53.68 (+0.53), QLIK: 39.94 (-0.63), KHC: 77.38 (+0.97), GOOGL: 658.27 (+3.50), ULTA: 166.39 (-3.15), CMCSA: 61.11 (-1.06), GIS: 56.96 (+0.04), SNDK: 61.16 (-0.68)
Which Big-Cap Stocks Are Defying Market Pressure?
at Investor's Business Daily - Mon Jul 27, 5:46PM CDT
When an uptrend comes under pressure, some stocks show action worthy of a drumroll, while others inspire eye rolls. The recent trouble for the uptrend started after the July 20 close. The S&P 500 suffered four distribution days in a row through...
BIIB: 309.43 (+9.40), MNST: 148.76 (-0.13), VRX: 257.30 (+5.38), GILD: 110.54 (-2.29), CMG: 731.44 (+2.65)
5 Things Biogen's Management Wants You to Know
Brian Orelli, The Motley Fool - Motley Fool - Mon Jul 27, 5:00PM CDT
Biogen held a conference call in conjunction with its second-quarter earnings last week. Here are five things that management said that investors should be paying attention to. "We had expected to see a reacceleration of Tecfidera this quarter,...
BIIB: 309.43 (+9.40)
Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
at The Street - Mon Jul 27, 3:30PM CDT
People are "max negative" on Twitter ahead of its earnings report Tuesday, which Jim Cramer doesn't see as unjustified -- at least, in the short term.
AGN: 326.98 (+18.77), BIIB: 309.43 (+9.40), GILD: 110.54 (-2.29), TEVA: 72.00 (+10.15), TWTR: 34.70 (-0.72)
Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.43 (+9.40), PRGO: 193.60 (+7.10), XOM: 79.26 (-0.68), MYL: 56.37 (-9.57), BMY: 64.30 (-1.68), AGN: 326.98 (+18.77), ISRG: 544.15 (-1.93), SBUX: 56.98 (-0.31), HCA: 92.03 (-0.80), IBM: 159.07 (-0.68), GM: 31.05 (-0.01), TEVA: 72.00 (+10.15), SPLK: 70.60 (-3.31), REGN: 540.03 (-1.82), NVS: 101.54 (-0.26)
4 Stocks Breaking Out on Big Volume
at The Street - Mon Jul 27, 1:30PM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
BIIB: 309.43 (+9.40), TERP: 31.33 (+0.48), WAB: 97.93 (+6.59), ENTA: 47.47 (+2.28)
Cramer -- Intel's a Few Bucks Away From a Buy, but PayPal Is One Right Now
at The Street - Mon Jul 27, 11:32AM CDT
Tech stocks were on the minds of viewers Monday morning when they posed their questions to TheStreet's Jim Cramer, including Intel, T-Mobile and PayPal.
BIIB: 309.43 (+9.40), GILD: 110.54 (-2.29), ALTR: 48.92 (-0.19), XON: 54.57 (-2.29), PYPL: 36.39 (-0.61), TMUS: 36.50 (-0.90), TWTR: 34.70 (-0.72), INTC: 28.35 (+0.29)
Cramer -- Be Careful Buying GrubHub, Biogen Is a Battleground
at The Street - Mon Jul 27, 10:38AM CDT
Jim Cramer is not hungry for GrubHub and says Biogen is turning into a battle royale for biotech investors.
BIIB: 309.43 (+9.40), GRUB: 31.01 (-2.78), XBI: 251.78 (-3.60), IBB: 373.58 (-4.00), REGN: 540.03 (-1.82), CELG: 132.56 (-2.34)
Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog
Arpita Dutt - Zacks Investment Research - Mon Jul 27, 9:58AM CDT
Biogen's (BIIB) shares lost more than 20% on issues regarding its oral MS treatment as well as disappointing pipeline updates.
BLUE: 159.49 (+0.58), BIIB: 309.43 (+9.40), LGND: 102.55 (+0.46), AMGN: 165.54 (+6.95), REGN: 540.03 (-1.82), EXEL: 5.44 (-0.15), CELG: 132.56 (-2.34)
3 Signs That the Healthcare Stock Bubble Might Have Just Popped
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 9:42AM CDT
Over the past five years or so, healthcare stocks have been absolutely trouncing the broader markets, leading many to call this unprecedented bull run a "bubble." A deeper look, though, reveals that most of this hypergrowth in the healthcare...
BIIB: 309.43 (+9.40), ILMN: 217.27 (-3.83), ABBV: 69.34 (+1.26)
3 Great Values to Buy on the Nasdaq - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 9:42AM CDT
Since the long term holds good for stocks listed on the Nasdaq, it will be a prudent idea to invest in value stocks despite short-term volatility.
SGYP: 8.19 (+0.28), AMZN: 531.41 (+1.99), BIIB: 309.43 (+9.40), TTMI: 9.14 (-0.01), FB: 94.17 (-2.78), NFLX: 106.43 (-2.91), YHOO: 37.83 (-1.02), QCOM: 61.98 (+0.34), GOOGL: 658.27 (+3.50), ANAC: 144.30 (-3.95), MSFT: 45.35 (-0.59), TECD: 55.52 (+0.51), AAPL: 122.77 (-1.73)
Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up
at The Street - Mon Jul 27, 9:30AM CDT
After cutting its revenue growth forecast, will Biogen buy itself back into investors' good graces?
BLUE: 159.49 (+0.58), BIIB: 309.43 (+9.40), NBIX: 49.34 (-2.16), ISIS: 53.68 (+0.53), SRPT: 32.00 (-0.63), RCPT: 227.09 (-0.91)
Biogen (BIIB) Stock Rebounding Following Bernstein Upgrade
at The Street - Mon Jul 27, 9:30AM CDT
Biogen (BIIB) stock is up after analysts at Bernstein raised their rating to 'outperform' from 'market perform' this morning.
BIIB: 309.43 (+9.40)
Stock Market News for July 27, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 9:10AM CDT
Declines in biotech and commodity related stocks dragged benchmarks down to on the red on Friday
BIIB: 309.43 (+9.40), AMZN: 531.41 (+1.99), MON: 101.46 (-1.40), COP: 50.65 (-1.44), AMGN: 165.54 (+6.95), XOM: 79.26 (-0.68), SLB: 81.76 (-1.14), CELG: 132.56 (-2.34), RIG: 13.11 (-0.15), GILD: 110.54 (-2.29), DD: 56.73 (-0.21), PX: 111.82 (-1.16), CVX: 89.14 (-1.46), DOW: 45.63 (-0.34), REGN: 540.03 (-1.82)
Biogen Enters Collaboration with the Parkinson's Institute and Clinical Center
Business Wire - Mon Jul 27, 6:30AM CDT
Biogen (NASDAQ:BIIB) and the Parkinson's Institute and Clinical Center today announced the formation of a strategic alliance focused on enhancing the understanding of the underlying biology of Parkinson's disease (PD) and the creation of novel tools and programs that could accelerate research and the development of new PD treatments. The agreement will combine the unique clinical expertise and data of the Institute with Biogen's focus on neurodegenerative disease and approach to clinical development.
BIIB: 309.43 (+9.40)
FCX, CLF, BIIB, COF: Jim Cramer's Views
at The Street - Mon Jul 27, 12:00AM CDT
Jim Cramer shares his views on a really bad day and when a leader stumbles. Freeport McMoRan, Google, Biogen and Capital One are among the many stocks discussed here.
BIIB: 309.43 (+9.40), COF: 78.61 (-0.25), GILD: 110.54 (-2.29), FCX: 11.37 (-0.92), RCPT: 227.09 (-0.91), CLF: 2.40 (-0.06), REGN: 540.03 (-1.82), CELG: 132.56 (-2.34)
Biogen Changed the Perception of This Market
at The Street - Sun Jul 26, 5:00PM CDT
Its large drop made people take notice of the haves-have-nots divergence.
BIIB: 309.43 (+9.40), AAPL: 122.77 (-1.73)
BUYINS.NET: WDR, BIIB, LEA Expected To Be Up Before Next Earnings Releases
M2 - Sat Jul 25, 5:06PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and earnings reports. Waddell & Reed Financial Inc (NYSE:WDR), Biogen Idec Inc (NASDAQ:BIIB), Leader Energy Services Ltd (NYSE:LEA) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up Before earnings are released Tuesday:
BIIB: 309.43 (+9.40), WDR: 43.35 (-0.10), LEA: 99.68 (+0.09)
'Fast Money' Panel Weighs Whether to Buy Stocks, Oil on Recent Decline?
at The Street - Sat Jul 25, 4:00AM CDT
The CNBC "Fast Money" traders look at recent earnings and consider whether dips in stock and oil prices present opportunities for investors.
VLO: 64.38 (-1.32), BIIB: 309.43 (+9.40), AMZN: 531.41 (+1.99), BX: 38.10 (-0.16), TSO: 97.11 (-1.83), C: 57.96 (-0.74), GOOGL: 658.27 (+3.50)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jul 24, 7:26PM CDT
Cramer says investors need to keep their powder dry and pounce when the markets put high-quality domestic stocks on sale.
DHI: 26.74 (+0.01), AMZN: 531.41 (+1.99), BIIB: 309.43 (+9.40), CY: 11.57 (-0.31), NSC: 82.80 (-0.16), MDLZ: 42.03 (unch), FB: 94.17 (-2.78), XOM: 79.26 (-0.68), CZR: 4.92 (+0.08), SBUX: 56.98 (-0.31), NFLX: 106.43 (-2.91), CI: 145.90 (+0.18), UA: 96.43 (+0.38), ANTM: 151.50 (+0.64), RLGT: 6.77 (-0.09), BIDU: 197.68 (-8.57), COF: 78.61 (-0.25), GILD: 110.54 (-2.29), R: 87.32 (-0.40), DD: 56.73 (-0.21), GOOGL: 658.27 (+3.50), PG: 79.97 (-0.32), TWTR: 34.70 (-0.72), PEIX: 7.56 (+0.23), CVX: 89.14 (-1.46)
